In this follow-up to the previous Doc Gumshoe missive about cancer, entitled “Cancer 2023 – What’s Happening in the Combat Zone,” which posted on July 18, we’ll be discussing several general types of cancer – brain, lung, ovarian, breast, liver, and cancer caused by obesity. In each case, however, there are special conditions associated with […]
6 Comments Read MoreArticles
Cancer 2023 – Second Installment
Cancer 2023: What’s Happening in the Combat Zone?
Just over 50 years ago, President Richard M. Nixon signed into law the National Cancer Act of 1971, which established the National Cancer Institute. Cancer had become the second leading (after heart disease) cause of death in the US in 1970. The National Cancer Institute (NCI) from its establishment had broad powers, including the creation […]
26 Comments Read MoreMarch 2023 Miscellany
A Change in the Testing Process as a Way to End the COVID-19 Pandemic – and a Couple of Other Possibly Promising Innovations
Doc Gumshoe looks at testing, herd immunity, and a few updates in diabetes and lung cancer
27 Comments Read More 
Cancer Care: Where Are We and Where Are We Headed?
[ed note: Michael Jorrin is a longtime medical writer (not a doctor) who covers health and medical topics and trends for our readers, generally without an investment thesis. His words are his own, enjoy!] In the Doc Gumshoe blog about cancer that appeared in June of 2013 (you can check it out here), I commented […]
36 Comments Read MoreWe use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.
More Info
Comments
Ditto. Both of my parents were smokers and both had lung cancer when they died. One of the reasons I started looking to...
OCX had big news today with success with its lung cancer treatment. Jumped up over 30% this morning, now up about 20%. M...
Recently I became aware of a YouTube by Dr Andrew Kaufman and exosomes. Dr Kaufman maintains that these normal cellular ...
Medical errors...third leading cause of death in US. This includes prescribed medicines taken as ordered by doctors, no...
Not to be a downer, my brother died of brain and lung Cancer, he spent many hours per day on his cell phone, odds are ...
Great article Doc. Any thoughts on Tagrisso: "In a clinical study, people taking TAGRISSO for metastatic non-small ce...
I reply to this comment specifically. The "CARCINOGENS IN MARIJUANA SMOKE" are to a large extent overcome in the user b...
Genprex, Inc. (GNPX) - Rodney Varner, Chairman and CEO, remarked during the recent Clinical and Corporate Update for Sec...
Please #StandWithMe in #Actions & #Prayers that my #BrotherInChrist, Charles Hielscher IS #HEALED, MADE Whole In The Na...
Yeah, but the 5 year survival rate for non-early stage lung cancer is still a joke. Over the past 35 years I have lost ...
$SIX:MOLN > INTERIM MANAGEMENT STATEMENT Q1 2018 http://e1.marco.ch/publish/konsulenten/8f7bfe72/tner_interest_underlin...
#EndPoints Early Edition NEWNovartis poaches Bristol-Myers/Amgen vet John Tsai for top drug development post in a ...
$HTBX - Heat Biologics Announces Positive Interim Data from its Phase 2 Clinical Trial of HS-110 and Nivolumab in Non-Sm...
$HTBX - Heat Biologics Receives Recommendation from Independent Data Monitoring Committee to Continue Enrollment of Phas...
Most of the potheads I knew that died didn't die of cancer. They died of liver disease from alcohol. It's a horrible d...
$HTBX long Some Salient points regarding Heat biologics1) The company is evaluating the lead product 110 in combin...
$HTBX LONG30-Jan-2018:07:00:00, Heat Biologics to Host Analyst and Investor Event February 28, 2018 to Present Re...
$NT. Dr. KSS. About 30 years ago a Dr. client of mine who smoked got lung cancer and told me he was going to beat it wi...
NEWLooking for a come-from-behind win, Roche touts its pivotal success for Tecentriq combo in front-line lung cancer...
$HTBX #HeatBiologics Receives #FDA Guidance at Type C Meeting for HS-110 Clinical Trial in the Treatment of Non-small Ce...
Abivax shares under pressure this morning on news being reported by Bloomberg that a lung cancer patient treated with $B...
$TRIL - Society for Neuro-Oncology 22nd Annual Meeting poster: http://s2.q4cdn.com/772010778/files/doc_presentations/20...
I had lung cancer, got it treated with the Cyberknife of Accuray, and have been cancer free for two years now. The treat...
$SNDX LONGsecond at peak 04:40 SNDX Syndax Pharmaceuticals presents ENCORE 601 data that continues to support...
$RXDXA nice interview with Ignyta’s CEO, Dr. Jonathan Lim, published in Rare Disease Report on November 8. Some Gu...
$HALO From their report: "In November 2015, we initiated a Phase 1b study exploring the combination of PEGPH20 and KEY...
$TRIL - November 18, 2017 05:00 PM PST San Francisco, CA Presenter: Zezhou Wang, Ph.D., Trillium Research Scientist h...
Tiny Ignyta's Lung Cancer Drug Bested Pfizer's. Probably. Will We Ever Know For Sure? https://www.forbes.com/forbes/wel...
$LUNG - PROLUNG SETS TERMS FOR $7 MILLION IPO October 17, 2017 ProLung, which is developing a test that predicts early...
RXDX - Interim Analysis of Ignyta's Entrectinib Suggests Potential Best-in-Class Profile as a First-Line Targeted Therap...
RXDX longIgnyta has updated ongoing Phase 2 data for entrectinib. The results appear to be very positive and in lin...
Long $ MRTXMirati Therapeutics price target raised to $20 from $13 at SunTrust SunTrust analyst Peter Lawson rais...
Long. $RxdxFollow to Ling Ling PostIgnyta Highlights from Our KOL Call on the ROS1 / TRK Space - ALERT Last we...
$RXDXIgnyta’s (RXDX) Buy Rating Reaffirmed at J P Morgan Chase & Co, PT=$20 Friday, October 13th, 2017J P...
$MRTXMirati Therapeutic’s Mocetinostat was selected to participate in the prestigious SU2C program to bring cuttin...
$BIOC - Renowned Lung Cancer Expert Fred R. Hirsch, M.D., Ph.D. Joins Biocept's Clinical Advisory Board http://www.prne...
$ MRTX LONGMirati Therapeutics data likely to be positive, says SunTrust SunTrust analyst Peter Lawson believes...
$RXDX - Ignyta Announces Updated Data on Entrectinib in ROS1 NSCLC to Be Presented at the IASLC 18th World Conference on...
$MRTXMore details about the Oppenheimer coverage:"Oppenheimer analyst Leah R. Canninitiated coverage with a Buy...
$MRTXDoc, many thanks for your insightful comments. As I understand it the detailed data set will be, or has been, r...
$MTRX np - Mirati Therapeutics Presents Positive Preliminary Data From On-Going Clinical Trials Of Sitravatinib In Non-S...
$RXDX(Great new data! RXDX up 9.5% in PM)Ignyta Provides Update on Entrectinib and RXDX-105 at the ESMO 2017 Co...
$RXDX - Ignyta Provides Update on Entrectinib and RXDX-105 at the ESMO 2017 Congress http://www.businesswire.com/news/...
$RXDX - gnyta Provides Regulatory Update on Entrectinib ROS1 Lung Cancer Development Program https://ignyta.com/investo...
$RXDX - Ignyta to Host Conference Call and Webcast on Entrectinib ROS1 Lung Cancer Update on September 6, 2017SAN DI...
$RXDX long.Ignyta to Host Conference Call and Webcast on Entrectinib ROS1 Lung Cancer Update on September 6, 2017SA...
I smoked from teenage years until 1989 and kept having trouble with my tonsils every year i was diagnosed with asymmetri...
$BIOC np - Biocept and UT Southwestern Medical Center Announce Clinical Study to Profile and Monitor Non-Small Cell Lun...
$TRIL $CD47Ladenburg report on Trillium's 2nd quarter: (8/12)In excerpts: 2Q17 Results. TRIL reported a net lo...
New genes discovered regulating brain metastases in lung cancer patients https://www.sciencedaily.com/releases/2017/08/...
$KALA ? np - Protein nanocages that penetrate airway mucus and tumor tissue http://www.pnas.org/content/114/32/E6595.a...
$RXDX long - https://ignyta.com/investors/press-release-article/1036548/Company HighlightsUpdated Progress Towar...
We've said it before: PD-1 checkpoint inhibitors ARE NOT created equal though they "seem" to act on the same pathway. Ca...
$SNDX- Yes this is 2 separate data readouts. SNDX's Entinostat has a breast cancer trial going on as well as an Imunoonc...
$TRILTrillium Provides Update on Small Molecule ProgramsIn excerpts: "Trillium has applied its unique medicin...
The latest in precision medicine for lung cancer. http://blog.aacr.org/fda-approves-new-lung-cancer-treatment-and-first...
Todd, I just read your post on the main thread, and I am so glad for you to hear of such hope for your wife's cure. It...
A close friend of mine has ALK lung cancer. Do you know of any biotechs Working on this cancer?...
$AFMD Long - sorry for the long post but it took me awhile to locate the abstracts so I thought I'd post for others who ...
I need to take my daughter to the dentist, but wanted to throw this out there--yesterday (or this morning?) $VBLT releas...
Another political scam. Big Tobacco money was supposed to help victims fight lung cancer and other medical conditions...
$TRIL: a recent report from Ladenburg Thalmann, post-ASCO17TRILLIUM THERAPEUTICS INC.TTI-621 Expands Several New...
$LOXO: Paradigm shift's afoot at Biotech's most prestigous conference ASCO17 with Gene-targeted or "tissue agnostic" whe...
Thanks Doc. I do have a question (or series of questions), but it is/they are so basic that I am wary about taking up ev...
$SNDXSyndax Pharmaceuticals (SNDX): Early Ph2 Data Encouraging - Citi's new TP=>$24 May 18, 2017 7:25 AMCi...
$SNDX Announces Advancement of ENCORE 601 in Non-Small Cell Lung Cancer Patients with Disease Progression on or After PD...
$ VBLT Long11-May-2017:07:00:00, VBL Therapeutics Presents Data on VB-111 in Combination with Checkpoint Inhibitor...
$BIOC long - The Addario Lung Cancer Medical Institute and Biocept Announce Collaboration and Initiation of Landmark ALC...
$BIOC news,,,I apologize if this has been posted. Seems long term agreement with $CPRX to test small cell lung cancer pa...
$BIOC long - Biocept and Catalyst Pharmaceuticals Collaborate to Provide Liquid Biopsy Testing for Small Cell Lung Canc...
$TSRO:TESARO Announces Fourth-Quarter 2016 Operating Results (2/28)HIGHLIGHTS:--Niraparib: NDA under review ...
I am sorry if I offended you Dave, I never knew your grandmother, so I was not casting aspersions on her lifestyle, but ...
$RXDX Long. Ignyta continues to climb, up another 10% today ($9.35). I have no special insight into long-term valuation ...
$CLRB long my first post here, asking for some insights to understand each segments of their business better. 1. live...
Gild: ''Gilead Sciences (GILD): 'Acquisition Wanted! - Please Apply Within' Following its 'kitchen sink' HCV guidance a...
Hi Doc, Thanks for the information. Again, I am skeptical, this one violates my "well-traveled drug" rule. It was approv...
Hi I have lung cancer been doing treatment no longer working would like to try this alpha cells treatment...
Bristol has abandoned plans to study nivolumab and Yervoy in lung cancer. But is not saying why so as "to protect the in...
Bloomberg's take on this development:"Bristol-Myers Falls Further Behind Merck in Lung Cancer Race"The shares fe...
Hi Everyone, FDA locked the gate on $BMY front-line lung cancer Tx. (Opdivo + Yervoy Accelerated pathway abandoned) in...
News report: Study suggests small cell lung cancer should not be treated as single disease http://www.cancerresearchuk....
Biotech is our chance for real cures, IMO - such as for cancer. My poor brother has small cell lung cancer, and if the...
A new research report on $MRK issued by BMO Capital on 1/10/17:"In Position to Meaningfully Strengthen Leadership ...
Berberine. Here is what I found at LEF.Com.Berberine is an alkaloid found in various different medicinal herbs. Prob...
$BIOC long and so is this post: Biocept Presents Robust Analytical Validation Study Results for its PD-L1 Liquid Biop...
PD-1 protein could serve as biomarker for predicting survival of lung cancer patients https://twitter.com/weldeiry/stat...
Thanks, Blue. Great article. Cimavax was developed to combat the high rate of lung cancer, which is understandable given...
I note that the NY Times and other papers have articles regarding cimavax, a Cuban vaccine to slow development of lung c...
CD47 Promotes Tumor Invasion and Metastasis in Non-small Cell Lung Cancer. http://www.sigmaaldrich.com/catalog/papers/27...
My brother was on nivolumab (lung cancer) and was taken off after having some of the more severe symptoms, and is still...
Merck with Keytruda wins early US approval with those with untreated lung cancer.http://www.reuters.com/article/us-m...
$BIOC no position. Good news.Biocept announces that clinical results from a study evaluating 40 patients with advanc...
$BMY's opdivo is still a good drug and valuable asset to the company, but data released since summer and confirmed last ...
I'm confused as to the recent Opdivo (nivolumab) conflicting news. One report says that this $BMY immunotherapy is a ga...
$BIOC - Clinical Results Demonstrating the Performance of Biocept's Target Selector Platform to be Presented at the 2016...
$KPTI - Karyopharm Publishes Preclinical Data in Nature Demonstrating Selinexor's Potential in KRAS-Mutant Non-Small Cel...
$RXDX - an interesting new article on Ignyta that provides excellent insights into the company’s past, present. and fu...
When Breath Becomes Air by Paul Kalanithi is an amazing book about death."At the age of thirty-six, on the verge of...
Checkpoint Inhibitors and Combination Therapy: the Future of Treatment for Non-small Cell Lung Cancer? https://twitter....